Original research
by
Meyer, Maximilian et al
Release Date
2023
Geography
Switzerland
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
Yes
Peer Reviewed
Yes
Objective
This cross-sectional study investigates the impact of benzodiazepine (BZD) use in opioid agonist treatment (OAT) patients on their quality of life (QoL).
Findings/Key points
The association of lower QoL and BZD use in OAT patients is strongly confounded by co-occurring depressive state and psychiatric symptoms.
Design/methods
Survey using a convenience sample (n=141)
Keywords
About PWUD
Mental health
